DRAP Hardship Drug Pricing Delay Squeezes Margins: SEARL, AGP in Focus
A backlog in DRAP's approval of hardship-case price increases is causing shortages of some essential medicines and squeezing margins on older, low-price product lines for branded pharma makers.